This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: University of Washington. Active years: 1998-2010.
Company Filing History:
Years Active: 1998-2010
Title: J Kelley Bentley: Innovator in Phosphodiesterase Research
Introduction
J Kelley Bentley is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of molecular biology, particularly in the study of phosphodiesterases. With a total of 4 patents to his name, Bentley's work has advanced our understanding of enzymatic activity and its modulation.
Latest Patents
Bentley's latest patents include groundbreaking inventions related to DNA encoding mammalian phosphodiesterases. The first patent focuses on novel purified and isolated nucleotide sequences encoding mammalian Ca/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). This invention also provides corresponding recombinant expression products, immunological reagents, and procedures for identifying compounds that modulate the enzymatic activity of these expression products. The second patent similarly addresses assay methods using DNA encoding mammalian phosphodiesterases, further emphasizing the importance of these nucleotide sequences in biological research.
Career Highlights
J Kelley Bentley is affiliated with the University of Washington, where he continues to conduct research and develop innovative solutions in his field. His work has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications.
Collaborations
Bentley has collaborated with notable colleagues such as Joseph A Beavo and Harry Charbonneau. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation.
Conclusion
J Kelley Bentley's contributions to the field of phosphodiesterase research exemplify the impact of innovative thinking in science. His patents and collaborations reflect a commitment to advancing our understanding of enzymatic processes, which may lead to significant advancements in medical and biological applications.